JANSSEN GLOBAL SERVICES LLC

In News

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer - Johnson & Johnson

Johnson & Johnson - Jul 17, 2025

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer - PR Newswire

PR Newswire - Jan 15, 2025

J&J Ends Trade Secrets Suit Against Now Deceased Ex-Exec - Law360

Law360 - Apr 22, 2025

Global Analgesics Market to Hit USD 75.73 Billion by 2032 - GlobeNewswire

GlobeNewswire - Dec 11, 2024

JEADV Clinical Practice | Clinical Dermatology and Venereology Journal - Wiley Online Library

Wiley Online Library - May 09, 2024

LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma | Leukemia - Nature

Nature - Mar 24, 2022

Janssen halts Phase III LOTUS trial of Stelara in SLE - Clinical Trials Arena

Clinical Trials Arena - Jun 29, 2020

Podoplanin Expression Measured By Flow Cytometry Accurately Identifies Patients with Acute Promyelocytic Leukemia at Diagnosis - ScienceDirect.com

ScienceDirect.com - Nov 02, 2023

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality - BMC Psychiatry

BMC Psychiatry - Aug 11, 2023

Psoriasis in Patients With Skin of Color - HCPLive

HCPLive - Feb 29, 2024

Multiple Sclerosis Therapeutics Market Size | CAGR Of 5.5% - Market.us

Market.us - Dec 20, 2024

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) outperforms osimertinib with a significant and unprecedented overall survival benefit in patients with EGFR-mutated non-small cell lung cancer - Johnson & Johnson

Johnson & Johnson - Mar 26, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI: Your Say